Prodia Widyahusada Tbk PT
IDX:PRDA
Prodia Widyahusada Tbk PT
IDX:PRDA
Price:
2 690
IDR
-0.37%
Market Closed
Market Cap:
2.5T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PRDA Alert
Prodia Widyahusada Tbk PT
2690
-10 (-0.37%)
| 52 Week Range |
2 610
5 450
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Prodia Widyahusada Tbk PT
Balance Sheet
Balance Sheet Decomposition
Prodia Widyahusada Tbk PT
Prodia Widyahusada Tbk PT
| Current Assets | 1T |
| Cash & Short-Term Investments | 732.9B |
| Receivables | 182.7B |
| Other Current Assets | 97.8B |
| Non-Current Assets | 1.7T |
| Long-Term Investments | 380.3B |
| PP&E | 1.1T |
| Intangibles | 248.4B |
| Other Non-Current Assets | 27.3B |
| Current Liabilities | 211.6B |
| Accounts Payable | 67.2B |
| Accrued Liabilities | 52.9B |
| Other Current Liabilities | 91.5B |
| Non-Current Liabilities | 128.7B |
| Long-Term Debt | 13.4B |
| Other Non-Current Liabilities | 115.3B |
Balance Sheet
Prodia Widyahusada Tbk PT
Prodia Widyahusada Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
45 112
|
44 977
|
1 177 490
|
788 429
|
102 484
|
91 852
|
364 988
|
607 833
|
698 403
|
542 960
|
|
| Cash |
45 112
|
0
|
0
|
0
|
0
|
0
|
214 988
|
307 833
|
598 403
|
372 960
|
|
| Cash Equivalents |
0
|
44 977
|
1 177 490
|
788 429
|
102 484
|
91 852
|
150 000
|
300 000
|
100 000
|
170 000
|
|
| Short-Term Investments |
9 189
|
6 798
|
11 540
|
200 000
|
835 000
|
920 000
|
769 554
|
899 850
|
499 951
|
449 853
|
|
| Total Receivables |
74 473
|
78 408
|
113 504
|
132 807
|
164 537
|
147 027
|
144 603
|
189 908
|
186 707
|
206 855
|
|
| Accounts Receivables |
74 473
|
78 408
|
113 504
|
132 807
|
164 537
|
147 027
|
139 430
|
185 773
|
182 293
|
201 273
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
5 173
|
4 135
|
4 414
|
5 582
|
|
| Inventory |
19 732
|
25 786
|
19 125
|
27 703
|
33 970
|
32 650
|
68 199
|
46 541
|
45 168
|
42 266
|
|
| Other Current Assets |
34 992
|
40 068
|
62 997
|
14 912
|
66 104
|
62 821
|
12 668
|
24 925
|
34 751
|
49 829
|
|
| Total Current Assets |
183 498
|
196 036
|
1 384 656
|
1 163 851
|
1 202 095
|
1 254 350
|
1 360 012
|
1 769 057
|
1 464 980
|
1 291 763
|
|
| PP&E Net |
362 907
|
196 284
|
225 645
|
410 272
|
519 806
|
517 906
|
812 148
|
878 590
|
958 353
|
1 016 736
|
|
| PP&E Gross |
362 907
|
196 284
|
225 645
|
410 272
|
519 806
|
517 906
|
812 148
|
878 590
|
958 353
|
1 016 736
|
|
| Accumulated Depreciation |
218 874
|
203 249
|
239 554
|
291 198
|
337 243
|
402 198
|
525 396
|
645 978
|
712 858
|
759 044
|
|
| Intangible Assets |
6 637
|
3 522
|
7 986
|
12 831
|
15 511
|
12 344
|
13 935
|
29 716
|
119 305
|
226 805
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
2 657
|
83 746
|
4 384
|
36
|
0
|
12
|
12
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100 000
|
148 741
|
|
| Other Long-Term Assets |
78 115
|
98 278
|
201 375
|
261 211
|
192 969
|
226 355
|
45 945
|
24 800
|
26 953
|
24 011
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
634 331
N/A
|
577 866
-9%
|
1 824 046
+216%
|
1 848 201
+1%
|
1 930 381
+4%
|
2 010 967
+4%
|
2 232 052
+11%
|
2 702 163
+21%
|
2 669 591
-1%
|
2 708 056
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
30 715
|
43 061
|
40 296
|
46 099
|
48 076
|
43 532
|
82 200
|
60 498
|
54 789
|
64 182
|
|
| Accrued Liabilities |
44 462
|
36 195
|
72 235
|
34 319
|
38 143
|
36 656
|
32 247
|
56 113
|
55 443
|
88 056
|
|
| Short-Term Debt |
5 732
|
1 000
|
23 461
|
0
|
0
|
0
|
0
|
50 110
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
31 541
|
18 855
|
22 541
|
20 192
|
22 515
|
12 145
|
21 982
|
13 639
|
14 192
|
12 929
|
|
| Other Current Liabilities |
33 421
|
45 986
|
34 394
|
46 507
|
55 549
|
51 221
|
73 726
|
88 550
|
105 800
|
69 863
|
|
| Total Current Liabilities |
145 871
|
145 096
|
192 926
|
147 117
|
164 283
|
143 554
|
210 155
|
268 910
|
230 224
|
235 030
|
|
| Long-Term Debt |
139 568
|
56 572
|
61 429
|
41 426
|
20 530
|
9 718
|
21 915
|
19 256
|
17 352
|
18 433
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 979
|
2 429
|
|
| Other Liabilities |
214 638
|
249 870
|
302 424
|
296 568
|
183 402
|
198 096
|
211 683
|
103 555
|
110 871
|
93 984
|
|
| Total Liabilities |
499 916
N/A
|
451 539
-10%
|
556 779
+23%
|
485 111
-13%
|
368 215
-24%
|
351 368
-5%
|
443 753
+26%
|
391 721
-12%
|
361 426
-8%
|
349 876
-3%
|
|
| Equity | |||||||||||
| Common Stock |
75 000
|
75 000
|
93 750
|
93 750
|
93 750
|
93 750
|
93 750
|
93 750
|
93 750
|
93 750
|
|
| Retained Earnings |
126 012
|
85 037
|
98 172
|
116 194
|
315 270
|
412 703
|
541 403
|
1 063 546
|
1 061 269
|
1 111 284
|
|
| Additional Paid In Capital |
0
|
25 370
|
1 153 146
|
1 153 146
|
1 153 146
|
1 153 146
|
1 153 146
|
1 153 146
|
1 153 146
|
1 153 146
|
|
| Other Equity |
66 596
|
59 080
|
77 801
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
134 416
N/A
|
126 327
-6%
|
1 267 267
+903%
|
1 363 090
+8%
|
1 562 166
+15%
|
1 659 599
+6%
|
1 788 299
+8%
|
2 310 442
+29%
|
2 308 165
0%
|
2 358 180
+2%
|
|
| Total Liabilities & Equity |
634 331
N/A
|
577 866
-9%
|
1 824 046
+216%
|
1 848 201
+1%
|
1 930 381
+4%
|
2 010 967
+4%
|
2 232 052
+11%
|
2 702 163
+21%
|
2 669 591
-1%
|
2 708 056
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
750
|
750
|
938
|
938
|
938
|
938
|
938
|
938
|
938
|
938
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
